Matches in SemOpenAlex for { <https://semopenalex.org/work/W2412131822> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2412131822 endingPage "7, 721, 720" @default.
- W2412131822 startingPage "684" @default.
- W2412131822 abstract "Recently, with the emergence of highly effective antiretroviral treatment (ART), chronic liver disease has become the leading cause of morbidity and mortality in co-infected HIV-HCV (Human immunodeficiency virus-Hepatitis C virus) patients. The overall SVR rate in this population remains unsatisfactory. The aim of this study was to evaluate the response to therapy in HIV-HCV co-infected patients in a single center.Consecutive HIV-HCV co-infected patients were evaluated in the liver clinic between 2003 -2010. Liver needle biopsy was conducted in 100% of the patients. The patients were treated by a multidisciplinary team consisting of immunologists, hepatologists, social workers and nurses and a close follow-up was conducted. The 48 weeks duration of peg-interferon and ribavirin combination was used for all genotypes according to recent guidelines. Weight-adjusted ribavirin doses were applied. Treatment was initiated after stabilization of HIV parameters and successful weaning from drug and alcohol addiction.A total of 86 out of 143 HIV- HCV co-infected patients, were evaluated; 39 completed treatment. Of those 31 (77%) achieved SVR. Out of 22 genotype 1 patients, 18 (82%) achieved SVR. Six patients had spontaneous viral clearance and 8 are still receiving treatment. In 17 non-one genotype patients, the SVR rate was 76.4% (13 of 17 patients); 6 patients were defined as relapsers and non-responders. Overall adherence to the treatment was high.Measures, such as the use of a multidisciplinary approach, high adherence of physicians to the guidelines, weight-based ribavirin dose, and selecting patients who are ready to start therapy, can significantly improve the SVR rate in this difficult-to-treat patient population." @default.
- W2412131822 created "2016-06-24" @default.
- W2412131822 creator A5013404999 @default.
- W2412131822 creator A5017227710 @default.
- W2412131822 creator A5031572282 @default.
- W2412131822 creator A5036214172 @default.
- W2412131822 creator A5042556662 @default.
- W2412131822 creator A5054439357 @default.
- W2412131822 creator A5070034615 @default.
- W2412131822 creator A5085537540 @default.
- W2412131822 date "2012-12-01" @default.
- W2412131822 modified "2023-09-23" @default.
- W2412131822 title "[Outcome of treatment with peg-interferon and ribavirin in HIV-HCV co-infected patients: real life single center experience]." @default.
- W2412131822 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23330260" @default.
- W2412131822 hasPublicationYear "2012" @default.
- W2412131822 type Work @default.
- W2412131822 sameAs 2412131822 @default.
- W2412131822 citedByCount "0" @default.
- W2412131822 crossrefType "journal-article" @default.
- W2412131822 hasAuthorship W2412131822A5013404999 @default.
- W2412131822 hasAuthorship W2412131822A5017227710 @default.
- W2412131822 hasAuthorship W2412131822A5031572282 @default.
- W2412131822 hasAuthorship W2412131822A5036214172 @default.
- W2412131822 hasAuthorship W2412131822A5042556662 @default.
- W2412131822 hasAuthorship W2412131822A5054439357 @default.
- W2412131822 hasAuthorship W2412131822A5070034615 @default.
- W2412131822 hasAuthorship W2412131822A5085537540 @default.
- W2412131822 hasConcept C126322002 @default.
- W2412131822 hasConcept C142462285 @default.
- W2412131822 hasConcept C203014093 @default.
- W2412131822 hasConcept C2522874641 @default.
- W2412131822 hasConcept C2776408679 @default.
- W2412131822 hasConcept C2776455275 @default.
- W2412131822 hasConcept C2776461080 @default.
- W2412131822 hasConcept C2780040827 @default.
- W2412131822 hasConcept C2908647359 @default.
- W2412131822 hasConcept C3013748606 @default.
- W2412131822 hasConcept C71924100 @default.
- W2412131822 hasConcept C90924648 @default.
- W2412131822 hasConcept C99454951 @default.
- W2412131822 hasConceptScore W2412131822C126322002 @default.
- W2412131822 hasConceptScore W2412131822C142462285 @default.
- W2412131822 hasConceptScore W2412131822C203014093 @default.
- W2412131822 hasConceptScore W2412131822C2522874641 @default.
- W2412131822 hasConceptScore W2412131822C2776408679 @default.
- W2412131822 hasConceptScore W2412131822C2776455275 @default.
- W2412131822 hasConceptScore W2412131822C2776461080 @default.
- W2412131822 hasConceptScore W2412131822C2780040827 @default.
- W2412131822 hasConceptScore W2412131822C2908647359 @default.
- W2412131822 hasConceptScore W2412131822C3013748606 @default.
- W2412131822 hasConceptScore W2412131822C71924100 @default.
- W2412131822 hasConceptScore W2412131822C90924648 @default.
- W2412131822 hasConceptScore W2412131822C99454951 @default.
- W2412131822 hasIssue "12" @default.
- W2412131822 hasLocation W24121318221 @default.
- W2412131822 hasOpenAccess W2412131822 @default.
- W2412131822 hasPrimaryLocation W24121318221 @default.
- W2412131822 hasRelatedWork W1968878988 @default.
- W2412131822 hasRelatedWork W2021484921 @default.
- W2412131822 hasRelatedWork W2033989269 @default.
- W2412131822 hasRelatedWork W2034228609 @default.
- W2412131822 hasRelatedWork W2082200384 @default.
- W2412131822 hasRelatedWork W2118320797 @default.
- W2412131822 hasRelatedWork W2161030888 @default.
- W2412131822 hasRelatedWork W2223925970 @default.
- W2412131822 hasRelatedWork W2341123991 @default.
- W2412131822 hasRelatedWork W57837434 @default.
- W2412131822 hasVolume "151" @default.
- W2412131822 isParatext "false" @default.
- W2412131822 isRetracted "false" @default.
- W2412131822 magId "2412131822" @default.
- W2412131822 workType "article" @default.